Lindahl advises Senzime AB on a directed new share issue of SEK 100 million
Lindahl has advised Senzime AB (publ) in connection with a directed new share issue that will provide the company with SEK 100 million before transaction costs.
The subscription price was determined through an accelerated bookbuilding process, with Carnegie Investment Bank acting as financial adviser.
About Senzime
Senzime AB is a company listed on Nasdaq Stockholm that develops and markets CE and FDA approved monitoring systems for patients undergoing anaesthesia.
Lindahl's team consisted of Mattias Prage, Andreas Mellberg and Michaela Larsson.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatMichaela Larsson
Associate | AdvokatCarousel items
-
Cases and transactions
11/20/2026
Lindahl represented a company in a successful case concerning intra-group accounting
Lindahl represented a company in a successful case clarifying the application of Swedish anti-money laundering law to intra-group accounting services.
-
Knowledge
11/19/2026
Payment difficulties on the client’s part
What should contractors know about their client’s finances? Explore insolvency, clawback risks and a new arbitral award relating to the Serneke bankruptcy.
-
News articles
10/14/2026
Lindahl once again recognised by IFLR1000
Lindahl is ranked in six practice areas in the latest IFLR1000 rankings, including a new ranking for Private equity. Seven of the firm's lawyers also receive individual recognition.
-
Portraits
7/3/2026
Jesper on business-oriented legal advice in energy: "It is not enough for the advice to be correct"
Lindahl's energy team is recognised in Legal 500 for combining deep regulatory expertise with broad commercial legal experience – find out how they support clients in a rapidly evolving sector.
-
Read more news and insights?